Portal de Periódicos da CAPES

Gamma Hydroxybutyrate (GHB) and Gamma Butyrolactone (GBL) Withdrawal: Five Case Studies

2001; Taylor & Francis; Volume: 33; Issue: 2 Linguagem: Inglês

10.1080/02791072.2001.10400479

2159-9777

Charles H. McDaniel, Karen Miotto,

Alcohol Consumption and Health Effects

Abstract There is little medical information available about gamma- hydroxybutyrate (GHB) or gamma-butyrolactone (GBL) dependence or withdrawal. In this study the authors treated and reviewed multiple cases of GHB and GBL withdrawal in high-dose users. Five patients during nine hospitalizations were treated for GHB or GBL withdrawal. The authors describe a spectrum of GHB or GBL withdrawal from mild to severe and discuss medications used for treatment. They conclude that patients with GHB or GBL withdrawal may present with agitated psychosis, delirium, and autonomic instability. In this sample, relapse to GHB or GBL use occurred soon after treatment of withdrawal.